Objective: To investigate and illustrate the use of statistical process control (SPC) for prospective monitoring and detection of regional changes in prescription opioid abuse rates. Methods: A demonstration project was conducted by applying several types of SPC charts to Louisiana TANF (Temporary Assistance for Needy Families) applicant self-reported opioid illicit use data collected during 21 months. These charts were constructed and examined for signals of abuse rate changes both at the aggregate statewide level and for each state region (parish) separately. Results: SPC identified increases in opioid illicit use in 2 parishes and subsequent decreases in both regions. These fluctuations were not as apparent when the data were examined using traditional bar graphs and summary tables. The remaining parishes exhibited stable abuse rates with no statistically significant changes over time. Conclusions: These results illustrate proof of concept for monitoring prescription drug abuse regionally via statistical control charts and the potential of this approach for real-time prospective surveillance for abuse rate changes.
P rescription pain medication abuse is a large and growing problem in the United States, with opioid analgesics being second only to marijuana as a substance used illicitly for nonmedical purposes. A 2007 national survey on prescription opioid abuse estimated that 5.2 million people in the United States used pain relievers nonmedically, with prescription opioids surpassing marijuana as the drug most often associated with drug initiation (ie, first drug used illicitly; Office of Applied Studies, 2008) for the first time since National Survey on Drug Use and Health household data have been collected. Increases in prescription opioid abuse gained widespread attention after the OxyContin problem that emerged in 2000 (Cicero et al., 2005) . Nonmedical use of OxyContin increased from 21,000 users the year it was introduced (1996) to 721,000 in 2003, a nearly 34-fold increase; by 2002, oxycodone and hydrocodone together comprised roughly 40% of all emergency department mentions of opioids in which the type of opioid product was reported (SAMHSA, 2004) .
Most current approaches to abuse detection, however, are too anecdotal, insensitive, or retrospective for informing interventions in a timely manner (Arfken and Cicero, 2003) , prompting several organizations to call for improved quantitative surveillance. A February 2005 meeting of the U.S. Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) concluded that real-time product-specific data remain essential but unavailable (Open Dialogue Meeting, 2005) . This need was underscored by the U.S. General Accounting Office (GAO) in their December 2003 report to Congress on the OxyContin problem, stating that the GAO could not assess the relationship between the increased availability of OxyContin and locations of abuse and diversion because the data on abuse and diversion are not reliable, comprehensive, nor timely (U.S. GAO, 2003) . In October 2004, the U.S. Department of Justice and the Office of National Drug Control Policy published the National Synthetic Drugs Action Plan (2004) : The Federal Government Response to the Production, Trafficking, and Abuse of Synthetic Drugs and Diverted Pharmaceutical Products, which recommended the following:
"Develop an early warning and response system . . . Particular focus should be given to earlier identification and routine detection . . . including the pursuit of additional data sources."
We describe a prospective surveillance approach that uses statistical process control (SPC) to monitor regional and local data in relative real time. As illustrated in Figure 1 and described in the Methods section, a statistical control chart is a longitudinal plot that monitors process data (here, abuse rates) over time to detect statistically significant changes, with values outside of statistical thresholds, runs above the median, or other nonrandom patterns indicating atypical events that warrant investigation and intervention. Originally developed to monitor manufacturing quality control data (Shewhart, 1931) , SPC has been applied to healthcare concerns since the early 1990s, primarily focusing on clinical processes, disease outbreaks, infection control, adverse events, medical errors, and patient safety (Benneyan, 1998a (Benneyan, , b, 2003 Curran et al., 2001; Brown et al., 2002) . Although this approach could be applied to any representative drug abuse data or type of drug, we illustrate the general concept using opioid illicit use data collected through Louisiana's Temporary Assistance for Needy Families (TANF) program. These data were used simply for demonstration purposes and we were given access to these data in the course of related work. Results of this pilot application data illustrate the potential of this approach as an adjunct to existent and mostly retrospective methods for these or other data.
Current Abuse Surveillance Data Systems
Most current abuse surveillance systems rely largely on some type of field observation or survey data gathered through treatment, medical, or criminal justice systems. A partial list of existing data sources that might be used for abuse monitoring are summarized in Table 1 and include, among others, the annual National Survey on Drug Use and Health community-based survey (Office of Applied Studies, 2008); Drug Abuse Warning Network Live! (DAWN Live!) data on drug-related emergency department visits and deaths (SAMHSA, 2003) ; state prescription monitoring programs (Brushwood, 2003) ; Drug Evaluation Network System FIGURE 1. General format of a statistical control chart with warning and control limits. (Cicero et al., 1999; Bennett et al., 2005) . National trends of drug abuse, including abuse of prescription opioids, are conducted yearly by the National Institute on Drug Abuse (NIDA) Community Epidemiology Working Group (CEWG, 2007) , and the National Drug Intelligence Center produces reports on trafficking and abuse of illicit drugs from a criminal justice perspective (NDIC, 2008) . Many surveillance systems, however, tend to be largely retrospective or qualitative, with limited ability to detect regional changes in abuse rates in relative real time. For example, DENS data do not tend to have broad geographic coverage, and Arfken and Cicero (2003) discuss the history and limitations of key informant networks. In contrast, public health and epidemiology tend to use more sensitive and quantitative surveillance methods, including the use of various time series methods to detect rate changes (Benneyan, 2006) . For example, the Scottish Surveillance of Healthcare Associated Infection Programme uses SPC for regional surveillance of antibiotic resistance in each of the 15 acute divisions and 12 boards in their national healthcare system (SSHAIP, 2003 (SSHAIP, -2006 .
METHODS

Data Source
Self-reported drug abuse data were collected during the 21 months from January 2002 through September 2003 from 11,100 of all 11,310 applicants (98.1%) to Louisiana's TANF program in all sites within all 10 TANF administrative regions of the state (Fig. 2) , including whether an applicant used prescription opioids nonmedically within the last 30 days. These data are collected routinely by the state when the applicants apply for TANF support using a multimedia version of the Addiction Severity Index (ASI), an instrument designed to assess an individual's severity of addiction and need for treatment on admission to a drug and alcohol program (McLellan et al., 1980 (McLellan et al., , 1992 . The ASI instrument has become a standard assessment of substance abuse across the county. The Veteran's Administration mandates use of the ASI, and it is used by many criminal justice agencies. The Joint Commission on the Accreditation of Healthcare Organizations recommends the ASI as part of a comprehensive assessment process, and about 30 states have some requirement for its use (eg, reporting of ASI summary scores required for reimbursement).
A multimedia version of the ASI, called the ASI-MV, conducts the survey through a self-administered computer interview that enables easier and more comprehensive data collection and has excellent psychometrics and reliability (Butler et al., 2001 ). The ASI-MV was included in a battery of assessments administered to all TANF applicants starting in January 2002, replacing the Drug Abuse Screening Test (Skinner, 1982) , which resulted in Ͻ2% of applicants being referred for substance abuse problems. After introduction of the ASI-MV, this percentage increased to 9%. Specifically, the ASI question used in this analyses is question D5 regarding any use or abuse by the respondent in the past 30 days of opiates or painkillers (other than heroin or methadone). The survey provides morphine, Darvon, Darvocet, Dilaudid, Talwin, and codeine as examples of such drugs.
Abuse rates in the TANF applicant population may not be the same as rates in the general population or even in the population of individuals with substance use disorders. Nevertheless, it is plausible that changes in abuse patterns in this population may correspond to similar directional changes in the general population, and therefore, such data might also be used to monitor for changes in the general and vulnerable populations.
Analytic Approaches
These data were examined using both quarterly descriptive statistics and SPC charts. Conventional analyses included bar charts and tables summarizing the percent of respondents reporting using each type of drug in the past 30 days, the percent of respondents using opioids illicitly in the past 30 days, the percent of respondents reporting chronic medical conditions, and regional and demographic information about respondents. These statistics were plotted on quarterly and semi-annual bar charts statewide and for each TANF administrative region separately. Self-reported illicit use was used as a proxy for abuse. Institutional Review Board approval was not required because all data were deidentified of client information.
For the SPC analysis, statistical control charts were constructed for the opioid abuse rate, which is defined as the percent of applicants who self-reported illicitly using prescription opioids in the last 30 days. Separate control charts were constructed for each individual region and for the entire state with all regions combined, with warning and control thresholds set per convention at 2 and 3 SDs on each side of the mean rate, respectively (alternate widths are discussed in the Discussion section). Because statistical control chart methods may not be familiar to some readers, we provide some general background below; for a more comprehensive discussion of SPC and its underlying theory, history, interpretation, and application to public health issues, readers are referred to Shewhart (1931) , Montgomery (2004) , and Benneyan et al. (1998a, b) .
Given that different types of control charts exist for different applications and types of signals, we applied several SPC methods to investigate their ability to monitor opioid abuse rates. These included conventional p control charts of the abuse rate, standardized Shewhart and exponentially weighted moving average (EWMA) charts, g charts for rare events (Benneyan, 2001) , charts for data aggregated across multiple non-homogeneous regions (i.e., with different abuse rates) (Benneyan et al., 2004) , and regular and non-homogeneous sequential probability ratio cumulative sum (CUSUM) charts (Taseli et al., 2008) . EWMA charts monitor a weighted running average of past data, rather than the weekly rate itself, with exponentially decaying weights given to past data to improve signal detection, magnifying small or sustained rate changes. CUSUM charts monitor a running total rather than an average of past data and exhibit similar signal detection performance to EWMA charts, both also filtering out random noise or short-term nonsystemic rate changes.
All these charts compute thresholds that are based on the underlying mean, SD, parameters, or probability distribution of the random variable being monitored (here, abuse rates) and between which nearly all observations are expected to occur if the rate remains unchanged (ie, if the null hypothesis is true). For example, for Gaussian (normal) data, the interval between 3 SDs above and below the mean in the long run should contain 99.73% of all observations if there is no change in causal processes; similarly, values should fall between 2 SD warning limits with roughly 95% probability, again assuming no change in the sampled population. Values outside these limits, conversely, indicate statistical changes, somewhat similar to interpretation of hypotheses test critical regions. Because the fraction of respondents reporting having used a drug illicitly follows a binomial (rather than normal) distribution under the null hypothesis of constant abuse rates over time, these percentages may differ very slightly, but the general interpretation is the same; if some other probability model were appropriate in other applications, then that model can be used to derive appropriate thresholds in a similar manner.
Control charts can be constructed based either on all time periods of data to look backward retrospectively or, more typically, on an initial baseline of data to monitor forward prospectively. To emulate how these methods would work for real-time prospective abuse monitoring, all baselines and thresholds were computed using only data from the first 23 weeks of data from February 3, 2002 through July 20, 2002. Data for the first month (January 2002) were available only for a few parishes, so control charts were constructed starting with February 2002 data. Each control chart was examined for signals of abuse rate changes. Signals were defined as any values outside the control limits or violating standard SPC runs rules (eg, 8 consecutive points above the median has a low probability of occurring, roughly 0.5 Ϸ 0.003 (Shewhart, 1931) , if the abuse rate does not change (Benneyan, 1998a, b) ), with data between the warning and control limits per convention considered as potential signals for early investigation on a smaller and less-expensive scale than values outside the wider threshold control limits. Interpretation of control charts is discussed further within the context of the results presented below.
RESULTS
Of the 11,310 TANF applicants, 210 (1.9%) did not submit an ASI-MV survey (for unknown reasons). Missing surveys were distributed among regions proportional to applicant volume (r ϭ 0.94), suggesting no systematic response difference among regions. Respondents were largely young (late twenties), almost exclusively female (97%), largely African American (84%), single (76%), poor ($380 mean monthly income), and with Ͼ50% having less than a high school education (Table 2 ). The ASI and ASI-MV typically are used to assess patients entering substance abuse treatment. The ASI composite scores of current problem severity suggest that this TANF population reports fewer problems in most of the assessed functioning areas than a demographically comparable (ie, age, gender, and race) cohort of substance abusers in treatment in the DENS database (Table 3) . Mean composite scores were significantly lower in all ASI domains (ie, medical, alcohol, drug, legal, social and family, and psychiatric status) except employment, which perhaps not surprisingly was slightly larger (0.78 for the TANF group vs 0.75 for the DENS data). Similarly, the medical and family/social composite means from the DENS sample (0.18 and 0.16, respectively) were only slightly greater than the TANF means (0.14 and 0.12, respectively). The alcohol, drug, legal, and psychiatric domains seem to reflect much larger differences between the 2 populations.
Opioid analgesics (3.4%), marijuana (3.0%), and sedatives (2.7%) were the most commonly used illicit drugs among survey respondents, with statewide rates 8 to 15 times higher than all other drug types (cocaine, barbiturates, methadone, heroin, amphetamine-like substances, and inhalants) and with opioids being the most common drug used illicitly. Table 4 summarizes the percentage of TANF admissions within each region that indicated opioid use in the past 30 days. As can be seen, opioid use varied significantly by geographic region ( 2 homogeneity test, 2 ϭ 230.6, df ϭ 9, P Ͻ 0.001) with regions 5 and 9 having the highest (9.7%) and second highest (7.0%) rates, respectively, followed by regions 6 (4.9%), 4 (4.8%), and 10 (4.0%). Pairwise comparisons reveal that region 5 has a statistically larger rate of prescription opioid abuse than all other regions, whereas region 7 is significantly lower than all others (0.5%). It is unclear what accounts for these differences within the state. Figure 3 summarizes abuse rates for the 2 regions with highest rates of prescription opioid use (regions 5 and 9) as detected by the ASI-MV, one of which (region 6) was identified in another study as having experienced increases in prescription drug problems during the study period (Duffy, 2004) and all other regions combined from quarter 2, 2002, through quarter 3, 2003. This time period was used because each region had at least 50 cases per quarter within this time frame. This figure exemplifies a fairly typical retrospective approach to trend analysis in which quarterly data are examined visually either in a bar chart or table. In this case, one can see a dramatic increase in regions 5, 6, and 9 between quarters 2 and 3, 2002 , and what appears to be a decrease by quarter 3, 2003.
Figures 4 and 5 illustrate several types of Shewhart, standardized, EWMA, and CUSUM statistical control charts for the percent respondents who reported illicit opioid use in the last 30 days statewide (Fig. 4) and in region 5 (Fig. 5) . Region 1 1.8% Ϯ 0.40% N ϭ 3098 t ϭ 1.5 t ϭ 1.4 t ϭ 4.9 t ϭ 11.1 t ϭ 5.1 t ϭ 4.2 t ϭ 2.9 t ϭ 7.9 t ϭ 3.9 df ϭ 3600 df ϭ 3278 df ϭ 3884 df ϭ 3939 df ϭ 3929 df ϭ 5262 df ϭ 3989 df ϭ 3921 df ϭ 4030
t ϭ 3.8 t ϭ 1.8 t ϭ 10.6 t ϭ 3.4 t ϭ 1.9 t ϭ 0.8 df ϭ 1629 df ϭ 1656 df ϭ 2989 df ϭ 1716 df ϭ 1611 df ϭ 1720 P Ͻ 0.001 P ϭ NS P Ͻ 0.001 P ϭ 0.001 P ϭ NS P ϭ NS Region 5 9.7% Ϯ 1.90% (N ϭ 843) -t ϭ 3.8 t ϭ 13.1 t ϭ 5.3 t ϭ 2.0 t ϭ 4.8 df ϭ 1674 df ϭ 3.7 df ϭ 1734 df ϭ 1666 df ϭ 1775 P Ͻ 0.001 P Ͻ 0.001 P Ͻ 0.001 P ϭ 0.05 P Ͻ 0.001 Region 6 4.9% Ϯ 1.93% (N ϭ 833) -t ϭ 8.3 t ϭ 1.6 t ϭ 1.8 t ϭ 0.9 df ϭ 2997 df ϭ 1724 df ϭ 1656 df ϭ 1765 P Ͻ 0.001 P ϭ NS P ϭ NS P ϭ NS Region 7 0.5% Ϯ 0.27% (N ϭ 2166) -t ϭ 6.3 t ϭ 10.6 t ϭ 7.2 df ϭ 3057 df ϭ 2989 df ϭ 3098 P Ͻ 0.001 P Ͻ 0.001 P Ͻ 0.001 Region 8 3.4% Ϯ 1.14% (N ϭ 893) -t ϭ 3.4 t ϭ 0.7 df ϭ 1716 df ϭ 1825 P ϭ 0.001 P ϭ NS Region 9 7.0% Ϯ 1.68% (N ϭ 825) -t ϭ 2.8 df ϭ 1757 P ϭ 0.006 Region 10 4.0% Ϯ 1.21% (N ϭ 934) -
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Figure 4 aggregates all statewide data together, with the control limits in the conventional p chart (Fig. 4A ) not being constant straight horizontal lines because of sample size differences in the weekly number of respondents. Figure 4B standardizes these same weekly abuse rates into a type of Z score by subtracting the binomial mean and dividing by its SD to produce constant limits for easier interpretation. Figure  5 illustrates the effect of taking a regional focus so that local rate changes are not diluted by the larger sample as well as the potential value of EWMA and CUSUM charts to improve signal detection and trend identification. Note that the statewide aggregate rate (Fig. 4 ) seems stable over most of the examined time period, with one isolated mild spike just above the upper control limit in the second week of December 2002, whereas for region 5 (Fig.  5) , there are at least 2 significant shifts in self-reported illicit opioid use, with a sustained increase starting roughly the week of July 21, 2002, and a subsequent decrease 8 to 9 months later. These rate changes are more evident on the EWMA (Fig. 5C ) and CUSUM (Fig. 5D ) charts than on the Shewhart charts (Figs. 5A and B) , with these more advanced methods smoothing out the noise in the raw data and both detecting these changes at about the same time. Given the similar performance and advantages of EWMA and CUSUM charts, and the more straightforward implementation and interpretation of the former, in most of our work, we are using EWMA charts with a conventional weighting parameter of ϭ 0.20 (although see comments in Discussion section). The cause of the statewide spike in December 2002 is unknown but could be due to a true one-time abuse increase in the TANF applicant population, a change in reporting accuracy, some other reason, or a type I error. It is doubtful however that the sustained increase observed in region 5 is a false positive given its prolonged duration. A similar pattern for region 6 is evident in Figure 6 , which while having a lower abuse rate than region 5 exhibits similar increases and decreases at roughly the same times. Note that regions 5 and 6 are geographically proximate, suggesting that this temporal cluster spans the 2 regions. Specific areas in region 6 have been reported elsewhere as having experienced increases in prescription drug problems (Duffy, 2004) .
In contrast, the abuse rate in region 9 remained high throughout the study period relative to the other parishes (also see Fig. 3 ) but is stable over time and exhibits only natural random variation with no statistically significant changes (Fig. 7) . This observation underscores the distinction between descriptive and statistical analysis (eg, bar charts and hypothesis tests) to identify differences between regional rates and surveillance to detect changes over time. That is, although regions 5 and 6 have lower abuse rates than region 9, they exhibit several rate changes of potential importance, whereas FIGURE 6. Region 6 control charts for fraction of Louisiana Temporary Assistance for Needy Families (TANF) applicants using opioids in last 30 days (standardized exponentially weighted moving average chart, with ϭ 0.20). Abuse rate exhibits an increase and decrease in approximately the same time periods as for region 5 (Fig. 5) . 
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J Addict Med • Volume 5, Number 2, June 2011 region 9 remains consistently high but unchanged throughout the study period. Similar regional control charts (not shown) were constructed for each of the other regions, with none exhibiting any significant rate changes throughout this time period, again contributing to the statewide dilution effect mentioned above in Figure 5 regarding nondetection of abuse rate changes in aggregated data and highlighting the value of regional monitoring.
DISCUSSION
Effective monitoring of drug abuse includes both retrospective analysis to describe historical activity and prospective surveillance to detect changes in relative real time. Possible types of signals could include sustained rate increases, isolated spikes, gradual trends, or changes in proportional abuse. The control charts presented in this article illustrate the ability of SPC to detect both increases and decreases in reported drug abuse in monitored populations. Although optimal selection and design of these charts is not the focus here, it is important to note that different types of control charts, limit widths, and various weighting and other design parameters yield different detection properties for each type of signal (eg, spikes, sustained shifts, small vs large changes, and gradual trends), with further investigation advised to determine the best methods for this type of drug abuse surveillance.
In general, it is desirable to select and design a control chart that will detect changes of important types and magnitudes with high probability and relatively quickly (ie, good sensitivity) but with low false alarm rates (ie, good specificity). Examples of SPC performance analysis and comparisons can be found in the study by Benneyan (1998a Benneyan ( , b, 2001 Benneyan ( , 2003 , Brown et al. (2002), and Montgomery (2004) and is the focus of an ongoing study specific to this type of application. Once a signal is detected, appropriate responses usually would be governed by the type of signal (spike, trend, and step increase), pervasiveness (isolated regionally or more widespread), and strength of the signal (magnitude of rate change and number of data sources generating signals).
In terms of the impact of sample sizes and control limit widths on statistical performance, monitoring small monthly samples on control charts can be effective even with fairly modest sample sizes, because of the accumulation and examination of data over time, with larger samples leading to faster detection. For example, it can be shown mathematically that a sustained abuse rate step increase from 0.075 to 0.15 would be detected by a p-type control chart in an average of either 4.8 or 1.5 months by using samples of either 50 or 150 respondents per month, respectively (Benneyan, 1998a, b) , and with false signals (given no abuse change) of points outside the limits occurring on average roughly every 280 and 236 months, respectively. Using some control limit width other than 3 SDs above and below the mean would change both detection speed and false signal frequency. Although further empirical and theoretical research should be conducted on the best tradeoff when applied to prescription opioid abuse surveillance, as a general rule, 2.5 to 3.5 SDs has been shown to be very robust in a wide range of applications and a good balance between true detection and false signals (Benneyan, 1998a, b; Montgomery, 2004) . More analytically, the sensitivity and optimization of control charts to detect rate changes of various magnitudes by using different sample sizes and limit widths are discussed further by Benneyan (1998a, b) .
Extending the SPC approach illustrated herein to a national monitoring system using appropriate data sources, ideally automated and including data on specific medication products abused, could be a valuable contribution to drug abuse surveillance. Although many data could be useful for this purpose, ASI-MV is one potentially viable source given that it is used routinely in various treatment and intervention seeking populations and because data collection makes few demands on agency staff. This latter point is important because healthcare workers often have poor compliance with data collection tasks (Mandl et al., 2004) . Such a nationwide system, called ASI-MV Connect, has been developed to collect use behavior for potentially addictive schedule II and III product-specific medications, uploading Health Insurance Portability and Accountability Act (HIPAA) compliant data in real time (on completion of the ASI-MV assessment) to a central server for potential analysis (Butler et al., 2008) . Similar systems have been used in public health for disease monitoring and outbreak detection for many years (eg, influenza, congenital birth defects, and respiratory illness) (Garnerin et al., 1992; Dessau and Steenberg, 1993; Benneyan et al., 2000; Brown et al., 2002) , with regional rate increases triggering localized interventions and more widespread trends triggering broader sets of actions. SPC combined with one or more appropriate drug abuse datasets might lead to similarly highly targeted and effective interventions.
Any national abuse monitoring system ideally would serve the 2 distinct general purposes of (1) rate estimation and (2) signal detection. Although the objective of this study was to demonstrate proof of concept for the second objective (monitoring), TANF population data are not typical for this purpose but were used here for illustration largely based on its statewide coverage and availability to the researchers. However, note that TANF or other ASI data may under-or overestimate abuse rates in the general population and may yield faster or slower detection if abuse is more or less prevalent in the data populations, respectively.
Although at this point we can only conjecture, it seems plausible that changes in abuse rates detected in this population may correlate to changes in other populations (eg, those in substance abuse treatment, admissions to emergency departments, and coroner reports) which in turn may reflect underlying abuse patterns in the general population. Thus, although one would expect (as we found above) abuse rates in a TANF population to be lower than a substance abuse treatment population, detection of relative temporal changes within this population still suggests the monitoring potential of applying SPC methods to ASI-MV or other data. Further work to correlate changes within these populations to each other and the general population would be helpful and is the focus of ongoing work.
Other potential limitations of this approach include the timely availability of accurate data, the effort required to synthesize and analyze such data, compliance and accuracy in completing the lengthy ASI instrument, and the potential for high false-positive rates resulting from simultaneously monitoring many regions and levels of aggregation. This last issue, essentially a multiple-testing Bonferroni problem, will be especially important to address if an automated system was developed to monitor abuse at numerous product and regional levels. Further testing in larger datasets that include additional states and episodes of increased abuse also will be helpful to more fully validate this approach. Beyond the methods illustrated here, more advanced statistical control charts could be used, which have greater theoretical sensitivity or that synthesize information from multiple data sources (treatment patients, key informant networks, diversion data, emergency department data, etc.).
As one example of an alternate SPC method particularly useful for low abuse rates, Figure 8 illustrates EWMA and CUSUM types of g control charts for region 7 (0.5% abuse rate). Although conventional p charts can have poor detection statistical power and false signal rates in such cases, these alternatives instead are based on the time between survey respondents, indicating illicit opioid use and result in more accurate interpretation (better sensitivity and specificity) (Benneyan, 2001) . Note that now an upward shift results from an increase in the time between reported abuse and thus a decrease in the reported abuse rate. In this case, note that the conventional Shewhart p chart in Figure 8A results in a majority of the plotted points equaling zero and a few apparent "spikes," whereas the EWMA and CUSUM charts in Figures 8B and C , respectively, reveal that the abuse rate is more likely to be stable over the examined time frame. Also note that unlike the other charts, on CUSUM charts, a downward trend or points beneath the lower limit indicate that the abuse rate has not changed (acceptance of the null hypothesis), as is the case here and agreeing with the EWMA chart that exhibits no indication of a sustained change in the abuse rate.
CONCLUSIONS
The SPC monitoring approach described in this article was shown in our pilot demonstration study to effectively detect increases and decreases in local prescription opioid illicit use rates using self-reported data collected from Louisiana TANF applicants through ASI-type surveys. Although further evaluation is necessary, this approach seems to be a useful complement to traditional semi-annual reports and other methods, with real-time prospective surveillance of regional data potentially enabling faster detection and better targeting of interventions. More accurate data sources and the application of SPC to other ASI data, such as respondent ASI scores or the number of days of illicit use within the last month, also might improve the ability to detect local changes in abuse rates. 
